Effect of antioxidant-rich propolis and bee pollen extracts against D-glucose induced Type 2 Diabetes in rats by Hassan Laaroussi et al.
Food Research International 138 (2020) 109802
Available online 15 October 2020
0963-9969/© 2020 Published by Elsevier Ltd.
Effect of antioxidant-rich propolis and bee pollen extracts against D-glucose 
induced type 2 diabetes in rats 
Hassan Laaroussi a, Meryem Bakour a, Driss Ousaaid a, Abderrazak Aboulghazi a, 
Pedro Ferreira-Santos b, Zlatina Genisheva b, José Antonio Teixeira b, Badiaa Lyoussi a,* 
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A B S T R A C T   
The present study was designed to investigate the preventive effect of propolis, bee pollen and their combination 
on Type 2 diabetes induced by D-glucose in rats. The study was carried out by feeding daily two concentrations 
(100 and 200 mg/Kg BW) of propolis or bee pollen (or their combination to normal (non-diabetic) and diabetic 
rats for a period of 16 weeks. In vivo biochemical changes associated to diabetes are induced by drinking a so-
lution containing 10% of D-glucose (diabetic rats). The in vitro antioxidant activity was also evaluated and the 
chemical composition of propolis and bee pollen extracts was determined by UHPLC-DAD. Phytochemical 
composition of propolis and bee pollen revealed the presence of several natural antioxidants, such as hydrox-
ycinnamic acids, hydroxybenzoic acids, flavonoids, flavan-3-ols and stilbens. The major antioxidant compound 
present in propolis was Naringin (290.19 ± 0.2 mg/Kg) and in bee pollen was apigenin (162.85 ± 17.7 mg/Kg). 
These results have been related with a high antioxidant activity, more intense in propolis extract. In rats, the 
administration of D-glucose had induced hyperglycemia (13.2 ± 0.82 mmol/L), increased plasmatic insulin 
levels (25.10 ± 2.12 U/L) and HOMA-IR index (14.72 ± 0.85) accompanied with dyslipidemia, elevation of 
hepatic enzyme levels, and a change in both serum renal biomarkers and plasmatic calcium. The co- 
administration of propolis and bee pollen extracts alone or in combination restored these biochemical param-
eters and attenuated the deleterious effects of D-glucose on liver and kidney functions. Furthermore, these effects 
were better attenuated in the combined therapy-prevented diabetic rats. Hence, it is possible to conclude that 
propolis and bee pollen can be used as a preventive natural product against diabetes induced dyslipidemia and 
hepato-renal damage.   
1. Introduction 
Type 2 diabetes (T2D) or non-insulin-dependent diabetes mellitus 
(NIDDM) is a chronic progressive disease characterized by chronic 
fasting hyperglycemia and resulting in defective insulin action (Associ-
ation, 2013). This pathology is most often linked to life style changes, 
obesity, physical inactivity and family antecedents. Currently, its inci-
dence is increasing exponentially, and affects more than 350 million 
people worldwide, estimates are that it will grow to about 642 million 
people by 2040 (Ogurtsova et al., 2017). Several hypotheses were put in 
place in order to explain the mechanisms involved in the manifestation 
of diabetes and its associated risks. The most solid one is that linking to 
oxidative stress, in fact hyperglycemia is a main factor triggering 
oxidative stress via the overproduction of reactive oxygen species (ROS) 
(Fakhruddin, Alanazi, & Jackson, 2017). In turn, the excess of ROS 
generated by hyperglycemia interact with the free and sulphydryl amine 
groups of the intracellular and extracellular proteins and subsequently 
forming the amadori products, which then will decompose and form the 
glycation products (AGEs) (Al-Malki, 2013). The chronic elevation of 
plasma glucose level has deleterious effects on the secretion of insulin 
from beta cells. Its action on peripheral tissues, blood vessels, nerve cells 
and other cell types is known as gluco-toxicity (Poitout et al., 2010). T2D 
can be associated with many complications affecting multiple organs 
such as eyes, kidneys, heart and brain (Sina, Graffy, & Simmons, 2018). 
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Diabetes mellitus (DM) induces diabetic nephropathy and diabetic 
hepatotoxicity through different mechanisms including, the activation 
of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase 
(MAPKs) signaling pathways as well as the down-regulation of nuclear 
factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) 
expression (Ebrahimi et al., 2019; Karim, Rahman, Changlek, & Tang-
pong, 2020). Undeniably, these complications could not just be due to 
the oxidative stress induced by diabetes but also due to the attenuation 
of the physiological defense system via glycosylation of the antioxidant 
enzymes. The relationship between diabetes, hepato-renal damage and 
oxidative stress has been the subject of previous studies (El Menyiy et al., 
2019; Ogar, Egbung, Nna, Atangwho, & Itam, 2019). 
Nature is an inexhaustible source of products and bioactive mole-
cules that can be used as alternative treatments, being propolis one of 
them. Propolis, known as a miracle drug, is a sticky, resinous substance 
made by a complex mixture of bee-released and plant–derived com-
pounds. In general, raw propolis is composed of around 50% resin, 30% 
waxes, 10% essential oils, 5% pollen and 5% of various organic com-
pounds (Al-Hariri, 2011). Phytochemical analyzes of propolis have 
revealed the presence of several bioactive molecules. Among these 
molecules we quote quercetin, phenolic acids and its esters, caffeic acid 
phenyl ester (CAPE) (Hoşnuter et al., 2004) steroids, terpenoids and 
amino acids (Burdock, 1998). Also, propolis has a very large fraction of 
minerals and trace elements including zinc (Zn) which intervenes as co- 
factors of antioxidant enzymes (Pietta, Gardana, & Pietta, 2002). 
Numerous studies have shown that propolis has different therapeutic 
properties such as antioxidant, antibacterial, antiviral, antifungal, 
anticancer, antiangiogenic and hepatoprotective (Sforcin & Bankova, 
2011). Furthermore, in vitro studies have shown that propolis inhibits 
α-amylase and α -glucosidase activities as part of its anti-hyperglycemic 
mechanism (El-Guendouz et al., 2016). 
Pollen is another bee product that is extremely rich in bioactive 
molecules, like flavonoids. Numerous biological effects are attributed to 
bee pollen, which include antioxidant (Leja, Mareczek, Wyżgolik, 
Klepacz-Baniak, & Czekońska, 2007), cardioprotective, hep-
atoprotective, and anti-inflammatory effects (Rzepecka-Stojko et al., 
2015). 
Until now, no study had examined the combined effect of propolis 
and bee pollen on type 2 diabetes and its related metabolic disorders. 
Therefore, the aim of this study was to determine the chemical 
composition of antioxidant polyphenols in propolis and bee pollen ex-
tracts and also to evaluate the influence of several doses of these extracts 
and their mixture in the prevention of T2D, dyslipidemia and hepato- 
renal dysfunction induced by D-glucose in rats. 
2. Materials and methods 
2.1. Propolis and bee pollen samples and extract preparation 
Propolis and fresh bee pollen samples were harvested, on May 2018, 
from hives installed in Skoura (Middle Atlas, Morocco) where the pre-
dominant vegetation consists of Pinus, sylvestris, Ceratonia siliqua, Ros-
marinus officinalis, Juniperus oxycedrus, Thymus vulgaris, Bupleurum 
spinosum, Globularia alypum and Cistus landanferus. The extracts were 
prepared by macerating 1 g of each sample in 30 mL of ethanolic 
aqueous solution (70% v/v) with mechanical stirring for one week at 
room temperature. The final extract was filtered, centrifuged at 3000 ×
g for 10 min and the supernatant was collected for further analysis. 
Subsequently, the filtrate was concentrated in a rotary evaporator. 
Distillated water was added to obtain two concentrations (100 and 200 
mg/kg BW) for animals’feeding (Park & Ikegaki, 1998). 
2.2. Chemical analysis of extracts 
2.2.1. Total phenolics content (TPC) 
The quantification of phenolics content was determined following 
the method of Folin-Ciocalteau described by (Miguel, Doughmi, Aazza, 
Antunes, & Lyoussi, 2014). 500 µL of Folin-Ciocalteau (0.2 N) reagent 
and 400 μL of sodium carbonate solution (7.5%) were added to 100 μL 
ethanolic extract of propolis or bee pollen. The intensity of produced 
color was measured at 760 nm (Perkin Elmer Lambda 40 UV/VIS 
spectrophotometer,) after incubating the mixture in the dark for 2 h. 
Gallic acid (0.071 to 0.719 mg/mL) was used as a standard to achieve 
the calibration curve (R2 = 0.999) and the result was expressed in 
milligram gallic acid equivalent (GAE) per gram of sample (mg GAE/g). 
2.2.2. Total flavonoids content (TFC) 
Total flavonoids were determined according to the procedure 
described by (Kong, Mat-Junit, Aminudin, Ismail, & Abdul-Aziz, 2012). 
Briefly, one hundred microliters of bee pollen or propolis ethanolic ex-
tracts was mixed with sodium nitrite (5%) and 150 μL of AlCl3 (10%). 
After 5 min, 200 μL of NaOH (1%) was added and placed in the dark for 
1 h. The intensity of the produced color was measured at 510 nm. 
Quercetin (0.261–1.423 mg/mL) was used as a standard to achieve the 
calibration curve (R2 = 0.997) and the flavonoids content was expressed 
in milligram of the quercetin equivalent (QE) per gram of sample (mg 
QE/g). 
2.2.3. Identification and quantification of polyphenols compounds by 
UPLC-DAD 
Samples were analyzed by Shimatzu N expera X2 UPLC chromato-
graph equipped with Diode Array Detector (DAD) (Shimadzu, SPD- 
M20A) according to the method described by (Ferreira-Santos et al., 
2019). Separation was performed on a reversed phase Aquity UPLC BEH 
C18 column (2.1 mm × 100 mm, 1.7 μm particle size; from Waters) and 
a precolumn of the same material at 40 ◦C. The flow rate was 0.4 mL/ 
min. HPLC grade solvents water/formic acid 0.1% (A) and acetonitrile 
(B) were used. The elution gradient for solvent B was as follows: from 0.0 
to 5.5 min eluent B at 5%, from 5.5 to 17 min linearly increasing from 5 
to 60%, from 17.0 to 18.5 min a linearly increasing from 60 to 100%; the 
column was equilibrated at 5% from 18.5 to 30.0 min. Phenolic com-
pounds were identified by comparing their UV spectra and retention 
times with that of corresponding standards. All standards used were of 
analytical grade (purity level above 94%) and procured from Sigma 
Aldrich (St. Louis, USA). Quantification was carried out using calibra-
tion curves for each compound analyzed using concentrations between 
250 and 2.5 mg/mL. In all cases, the coefficient of linear correlation was 
R2 greater than 0.99. Compounds were quantified and identified at 
different wavelengths (250–370 nm). All analyses were made in 
triplicate. 
2.3. Evaluation of in vitro antioxidant activity 
2.3.1. Total antioxidant activity (TAA) 
Total antioxidant activity of propolis or bee pollen samples was 
evaluated by the phosphomolybdenum method according to the method 
described by (Prieto, Pineda, & Aguilar, 1999). 1 mL of reagent solution 
(6 M sulfuric acid, 28 mM sodium phosphate and 4 mM ammonium 
molybdate) was added to 25 µL of ethanolic extract of propolis or bee 
pollen and the mixture was incubated for 90 min in a water bath at 
95 ◦C. After, the absorbance was read at 695 nm and ascorbic acid was 
used as the standard calibration (0.171to 0.872 mg/mL, R2 = 0.999). 
The results were expressed in milligram of ascorbic acid equivalent 
(AAE) per gram of sample (mg AAE/g). 
2.3.2. Free radical scavenging activity 
Free radical scavenging activity (DPPH assay) was measured ac-
cording to the method described by (Miguel et al., 2014). Briefly, 875 μL 
of 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) solution (63.4 μM, 
prepared in ethanol) was mixed with 25 µL of ethanolic extract of 
propolis or bee pollen, and the mixture reaction was incubated during 
one hour in the dark. The control consisted in using the solvent of 
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extraction instead of the sample. The absorbance was read at 517 nm 
and the antiradical activity (% inhibition) was estimated using the Eq. 
(1). DPPH inhibition concentration at 50% (IC50) is determined using 
five different dilutions of each sample, considering that the percent in-




× 100 (1)  
2.4. Experimental animal’s protocol 
Sixty six male wistar rats, 11 week old with 173 ± 3 g of body weight 
(BW), were used in this experiment. The animals were housed in a 
standard environmental condition (23 ± 3 ◦C with 12 h light/dark cy-
cles) and fed with standard rodent chow and water ad libitum. Ethical 
approval was obtained from Sidi Mohamed Ben Abdellah University, 
Fez, under the responsibility of the Animal Facility and the Laboratory of 
Natural Substances, Pharmacology, Environment, Modeling, Health and 
Quality of Life, University of Sidi Mohamed Ben Abdellah, Fez, Morocco 
(USMBA-SNAMOPEQ 2017–03). The care and handling of the animals 
were in accordance with the internationally accepted standard guide-
lines for the use of animals. 
Rats were randomly allocated into 11 groups of six rats. 
Groups 1 to 5 are considered normal non-diabetic control groups, 
whereas groups 6 to 11 are considered diabetic groups (induced by 10% 
D-glucose in drinking water throughout the study). 
Group 1: received daily by gavage distilled water (10 mL/Kg BW) 
and had free access to tap water; 
Group 2: received daily by gavage propolis extract (200 mg/Kg BW) 
and had free access to tap water; 
Group 3: received daily by gavage bee pollen extract (200 mg/Kg 
BW) and had free access to tap water; 
Group 4: received daily by gavage propolis extract (100 mg/Kg BW) 
and had free access to tap water; 
Group 5: received daily by gavage bee pollen extract (100 mg/Kg 
BW) and had free access to tap water; 
Group 6: had free access to a drinking solution containing 10% of D- 
glucose and received daily by gavage distilled water (10 mL/Kg BW); 
Group 7: had free access to a drinking solution containing 10% of D- 
glucose and received daily by gavage propolis extract (200 mg/Kg BW); 
Group 8: had free access to a drinking solution containing 10% of D- 
glucose and received daily by gavage pollen extract (200 mg/Kg BW); 
Group 9: had free access to a drinking solution containing 10% of D- 
glucose and received daily by gavage propolis extract (100 mg/Kg BW); 
Group 10: had free access to a drinking solution containing 10% of D- 
glucose and received daily by gavage bee pollen extract (100 mg/Kg 
BW); 
Group11: had free access to a drinking solution containing 10% of D- 
glucose and received daily by gavage 100 mg/Kg BW of propolis extract 
+ 100 mg/Kg BW of bee pollen extract. 
The study lasted for 16 weeks. At the end of study, fasted rats were 
anaesthetized with light diethyl ether. Blood sample was withdrawn 
from each rat by retro-orbital puncture, collected into tubes, and then 
plasma was separated by centrifugation (2000 × g) during 10 min. 
The treatment duration was chosen based on the results of (Katsuda 
et al., 2014; Ousaaid et al., 2020). The pollen and propolis extracts doses 
were selected according to (El Menyiy, Al Waili, Bakour, Al-Waili, & 
Lyoussi, 2016; El Ghouizi, El Menyiy, Falcão, Vilas-Boas, & Lyoussi, 
2020). 
2.4.1. Biochemical analysis 
Plasmatic levels of aspartate aminotransferases (AST), alanine ami-
notransferases (ALT), lactate dehydrogenase (LDH), alkaline phospha-
tase (ALP), triglycerides (TG), total cholesterol (TC), low-density 
lipoprotein (LDL-C), very-low-density lipoprotein (VLDL), high density 
lipoprotein (HDL-C), uric acid, creatinine, urea, albumin, total protein, 
blood glucose, plasma insulin levels were determined by radioimmu-
noassay method (Rat insulin RIA kit, Millipore, St Charles, MO, USA). 
Plasma, sodium (Na+), potassium (K+) were analyzed using ion-selec-
tive potentiometry method (Architect c8000i biochemistry analyzer), 
and plasma calcium (Ca2+) was determined basing on it reaction with 
Arsenazo III (2,2′-[1,8-Dihydroxy-3,6-disulphonaphthylene-2,7-bisazo]- 
bisbenzenear-sonic acid). The intensity of produced color was measured 
bichromatically at 660/700 nm (Architect c8000i biochemistry 
analyzer).. Model homeostasis evaluation (HOMA-IR) (Eq. (2)), and 
homeostatic model-β (HOMA-β) (Eq. (3)) were calculated following 
formula described by (Matthews et al., 1985), quantitative insulin 
sensitivity check index (QUICKI) (Eq. (4)) was determined according to 
(Katz et al., 2000). 






































2.4.2. Body weight change and organ weights 
The BW in each group of rats was measured at the beginning and at 
the end of the experiment using an electronic balance. Percentage 
changes were calculated by comparing the diabetic control group 
(Group 6) with normal non-diabetic group (Group 1) and the diabetic 
treated groups with diabetic control. Liver, pancreas and kidney were 
removed at the end of the study and weighted. 
2.5. Statistical analysis 
All data are presented as mean ± SD (standard deviation). Statistical 
comparisons between the groups were performed with one-way analysis 
of variance (ANOVA) followed by Tukey test using GraphPad Prism® 
software (version 5.0; GraphPad software, Inc., San Diego, USA). Sig-
nificance was accepted at p < 0.05. 
3. Results 
3.1. Phytochemical analysis and in vitro antioxidant activity of extracts 
As presented in Fig. 1, the chemical analysis shows that propolis 
contains 89.71 ± 5.12 mg GAE/g of total phenolic contents, total 
flavonoid content is 38.56 ± 2.47mgQE/g) and total antioxidant ca-
pacity is 96.17 ± 7.38 mg AAE/g. The phenolic and flavonoid contents 
in bee pollen sample are lower (19.68 ± 0.12 mg GAE/g and 7.35 ± 0.16 
mgQE/g, respectively); and the total antioxidant capacity is 26.46 ±
0.59mgAAE/g. Regarding free radical scavenging activity, DPPH test 
was evaluated and it showed the following results of IC50: 0.17 ± 0.00 
mg/mL for propolis and 0.91 ± 0.02 mg/mL for bee pollen. 
3.2. Polyphenols compounds identification 
Fourteen polyphenolic compounds were quantified in the propolis 
sample and thirteen were quantified in bee pollen (Table 1). As shown in 
Table 1, the major components detected in propolis were naringin 
(290.19 ± 0.2 mg/kg), hesperidin (271.77 ± 0.0 mg/kg) and rosmarinic 
acid (222.02 ± 6.2 mg/kg). However, apigenin (162.85 ± 17.7 mg/kg), 
rosmarinic acid (127.30 ± 6.2 mg/kg) and naringin (113.71 ± 6.8 mg/ 
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kg) were the most predominant polyphenolic compounds quantified in 
analyzed bee pollen. Other detected polyphenolic compounds are 
quercetin, gallic acid, kaempferol, chlorogenic acid, rutin, resveratrol, 
cinnamic acid, ellagic acid, ferrulic acid, o-coumaric acid, vanilic acid, 
catechin. However, cinnamic acid and gallic acid were not detected in 
propolis; kaempferol, chlorogenic acid and catechin were not detected 
in bee pollen. 
3.3. In vivo effects of propolis and bee pollen extracts 
3.3.1. Blood glucose and insulin resistance 
The administration of propolis and bee pollen extracts to non- 
diabetic animals has no effects in glycemia, insulinemia and associ-
ated parameters (Fig. 2). The data presented in (Fig. 2 A) shows a sig-
nificant increase (p < 0.001) in the fasting blood glucose levels of 
diabetic rats compared to the control groups. However, the adminis-
tration of propolis alone at a dose of 100 or 200 mg/kg BW and bee 
pollen at the same doses doesn’t affect the blood glucose level in non- 
diabetic control groups. While the co-treatment with propolis at the 
same doses induce a detectable decrease (p < 0.01) in the fasting blood 
glucose concentrations compared to control diabetic rats (Group 6). Also 
the co-administration of bee pollen at two tested doses (100 and 200 
mg/Kg BW) has significantly reduced the fasting blood glucose levels in 
comparison with non-treated diabetic rats (Group 6). Similarly, the co- 
administration of the mixture of propolis and bee pollen (Group 11) 
showed a strong decrease in the blood glucose levels compared to the 
control diabetic rats and the other treated diabetic groups. 
Fig. 1. A: Total phenolic content (TPC), B: flavonoids (TFC), C: Total antioxidant activity (TAA), and D: radical scavenging activity (DPPH) of propolis and fresh bee 
pollen extracts. 
Table 1 
Polyphenols compounds identification and quantification of propolis and fresh 
bee pollen samples using UPLC-DAD.  
Compounds (mg/kg) Propolis Bee pollen 
Hydroxycinnamic acids   
Ferrulic acid 40.60 ± 0.6 17.17 ± 0.4 
Cinnamic acid n.d. 46.01 ± 7.8 
o-Coumaric acid 35.47 ± 0.2 27.10 ± 1.9 
Chlorogenic acid 25.31 ± 0.0 n.d. 
Rosmarinic acid 222.02 ± 6.2 127.30 ± 6.2 
Hydroxybenzoic acids   
Gallic acid n.d. 32.54 ± 2.2 
Vanilic acid 10.58 ± 0.1 6.13 ± 0.1 
Ellagic acid 37.94 ± 0.1 13.02 ± 0.0 
Flavan-3-ols   
Catechin 18.83 ± 0.1 n.d. 
Flavonoids   
Naringin 290.19 ± 0.2 113.71 ± 6.8 
Hesperidin 271.77 ± 0.0 15.63 ± 6.8 
Quercetin 14.78 ± 0.2 48.12 ± 2.8 
Apigenin 50.37 ± 0.8 162.85 ± 17.7 
Kaempferol 26.48 ± 1.2 n.d. 
Rutin 34.37 ± 1.3 95.36 ± 3.7 
Stilbens   
Resveratrol 86.25 ± 0.2 44.00 ± 0.4 
Total 1165.0 ± 6.3 748.9 ± 56.8 
Values of polyphenols compounds are expressed in concentration (mg/kg) mean 
± SD of 3 experiments. n.d: not detected. 
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After 16 weeks of D-glucose intake, the plasmatic insulin levels 
increased significantly (Fig. 2 B). This increase was majorly prevented 
after oral co-administration of propolis (200 and 100 mg/kg BW) and 
bee pollen (200 and 100 mg/kg BW). The combined treatment of 
propolis and pollen (Group 11) showed a greater reduction of plasma 
insulin levels compared with animals treated with only one type of 
extract. 
Furthermore, the insulin resistance index estimated by HOMA-IR 
significantly increased (p < 0.001) in rats treated with D-glucose 
compared to the control non-diabetic group (Group 1). However, the 
treatment with propolis or bee pollen at two tested doses showed a 
significant reduction in HOMA-IR index and thus, insulin resistance in 
comparison with the non-diabetic control group. Moreover, the effect 
promoted by the extracts is dose dependent and the combined treatment 
with propolis and bee pollen reduce HOMA-IR (p < 0.001). In addition, 
the diabetic group (Group 6) expressed a very low value of HOMA-β. The 
co-administration of propolis, bee pollen or both showed a significant 
improvement of all these parameters, with the best data observed in the 
Fig. 2. Blood glucose, Plasma insulin, HOMA-IR index, HOMA-β, and QUICKI. a: comparison between the group 1 and all groups, b: comparison between the group 6 
and all groups, c: comparison between group 7 and group 11, d: comparison between group 8 and group 11(the significance started at p < 0.05). 
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rats which received the combined treatment of propolis and pollen ex-
tracts (Group11). 
3.3.2. Plasma lipid profile 
Fig. 3 shows the plasmatic levels of total cholesterol, triglycerides, 
HDL-cholesterol, LDL-cholesterol and VLDL-cholesterol. The diabetic 
group (Group 6) showed a significant increase in TC, TG, LDL-C and 
VLDL (p < 0.001) and decrease in HDL-C (p < 0.001) as compared to the 
non-diabetic groups (Groups 1 to 5). Treatment with propolis or pollen 
in non-diabetic rats has no effects in lipid profile, expressed similar 
values to the rats that received distilled water. The co-treatment with 
propolis or bee pollen at two tested doses, reversed these increases of TC, 
TG, LDL-C and VLDL promoted by D-glucose intake and leads to increase 
in HDL-C (p < 0.001). The results also indicate that the combined co- 
treatment of extracts (propolis + bee pollen) decreased plasmatic TC, 
TG, LDL-C and VLDL levels (p < 0.001) and increased HDL-C level (p <
0.001) as compared to the non-treated diabetic group (Group 6) or 
treated diabetic group with a single extract. 
3.3.3. Plasmatic determinations of renal biomarkers 
Fig. 4 represents the plasmatic levels of creatinine, urea, uric acid 
and total protein in the control and diabetic groups. The groups that 
receive 10% D-glucose (diabetic groups) depict a significant increase in 
the creatinine, urea, and uric acid levels (p < 0.001), and significant 
decrease in total protein and albumin levels (p < 0.001), compared to 
non-diabetic rats. The diabetic group treated with propolis or bee pollen 
(100 and 200 mg/kg BW) showed a significant reduction of serum 
creatinine, urea, uric acid and increase in total protein and albumin 
levels. The diabetic group (Group 11) treated simultaneously with 
propolis and bee pollen, showed a significant decrease in creatinine, 
urea, and uric acid (p < 0.001), and a significant increase in total protein 
and albumin compared to non-treated diabetic group (Group 6). 
Regarding plasma electrolytes, the data presented in Fig. 4 (F,G,H,I) 
showed that D-glucose treatment did not cause any significant changes 
in the serum level of sodium (Na+), potassium (K+) and chloride (Cl-). 
Whereas, it induced a significant decrease in plasma calcium (Ca2+) 
compared with the control group 6 (p < 0.05), however, the co- 
treatment with propolis, bee pollen or both of them has prevented the 
plasma calcium loss. 
3.3.4. Liver function 
The data in Fig. 5 indicates that diabetic animals expressed a sig-
nificant increase in ALT, AST, ALP and LDH compared to the control 
non-diabetic group (Group 1). Daily administration of propolis and bee 
pollen extracts did not show effects in the control animals, obtaining 
similar values to those of Group 1. The diabetic group co-treated with 
propolis or bee pollen at high (200 mg/kg BW) or a low (100 mg/kg BW) 
dose, alone or in combination showed a significant improvement in all 
biomarker levels in comparison with diabetic non-treated group (Group 
6). 
3.3.5. Body and organs’ weights 
The rats’ weights were measured at the beginning and at the end of 
the experiment. The derived data in table 2 increased significantly (p <
0.01) the final body weight and body weight gain in the diabetic rats 
compared to normal rats, the recorded percentage of changes were 
40.56% and 198.18% respectively. The administration of propolis at a 
high dose showed a significant decrease in the final body weight and 
body weight gain compared to the control group, with a percentage 
change of − 5.72% and − 36.32%, respectively. The co-treatment with 
propolis at a low (Group 9) and a high (Group 7) doses showed a sig-
nificant decrease in the final body weight and body weight gain in 
comparison with the diabetic group, and the recorded percentage 
changes were − 15.68% and − 39.90%, − 16.78% and − 44.58% respec-
tively. The administration of fresh bee pollen at a high dose recorded a 
final body weight and weight gain in comparison with the control group, 
the recorded percentage changes were 31.89% and 140.44% respec-
tively. The co-administration of propolis at a high and a low doses 
showed a significant decrease in the final body weight and body weight 
gain as compared to diabetic group, while the combined co-treatment 
showed a percentage change in final body weight and weight gain in 
comparison with the diabetic group − 13.53% and − 25.28% 
respectively. 
The body weight change was accompanied by the alteration of the 
liver, kidneys and pancreas weights. Table 3 showed that the treatment 
with propolis and bee pollen or both did not affect the organs’ relative 
weight. D-glucose chronic administration decreased significantly the 
relative weight of kidneys, pancreas and liver. However, the co- 
treatment with propolis, bee pollen and their combination improved 
significantly the organs’ relative weight, with the best recovery related 
to the co-treatment with the bee pollen (200 mg/kg BW). 
Fig. 3. TC, TG, LDL-C, HDL-C and VLDL levels. a: comparison between the group 1 and all groups, b: comparison between the group 6 and all groups, c: comparison 
between group 7 and group 11, d: comparison between group 8 and group 11 (the significance started at p < 0.05). 
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Fig. 4. Plasmatic levels of renal biomarkers, A: Creatinine; B: Urea; C: Uric acid; D: Total protein; E: Albumin; F: Calcium; G: Sodium; H: Potassium; I: Chloride. a: 
comparison between the group 1 and all groups, b: comparison between the group 6 and all groups, c: comparison between group 7 and group 11, d: comparison 
between group 8 and group 11 (the significance started at p < 0.05). 
Fig. 5. Effect of interventions on ALT, AST, PAL and LDH Levels. a: comparison between the group 1 and all groups, b: comparison between the group 6 and all 
groups, c: comparison between group 7 and group 11, d: comparison between group 8 and group 11 (the significance started at p < 0.05). 
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4. Discussion 
4.1. Phytochemical composition and antioxidant activity of propolis and 
bee pollen extracts 
Bee products are considered as a rich source of biological active 
compounds. In fact, their pharmacological accomplishments are attrib-
uted to phenol and flavonoids contents (Juszczak, Gałkowska, Ostrow-
ska, & Socha, 2016). The data showed that propolis and bee pollen 
extracts exhibited high antioxidant activity and expressed a strong free 
radical scavenging capacity. Indeed, the amount of phenolic content in 
our propolis sample was 79.71 ± 5.12 mg GAE/g, which was higher than 
that reported by (Miguel et al., 2014). For different Moroccan propolis 
samples, ranging from (0.74–65.7 mg GAE/g), that can be explained by 
botanical sources and pedoclimatic conditions. 
Due to the variety in the composition of food or other biological 
samples, studying the antioxidant compounds is very attractive for re-
searchers and industries due to its wide application. In this sense, the use 
of consistent and convenient methodologies for the rapid quantification 
of antioxidants is one of the important points in this type of studies. 
Normally, different in vitro assays, with different mechanisms of 
action, are needed to confirm the antioxidant properties of natural 
molecules, extracts and foods. In practice, several in vitro test procedures 
are carried out for evaluating antioxidant activities with the samples of 
interest. Another aspect is that antioxidant test models vary in different 
respects. Therefore, it is difficult to compare fully one method to other 
one (Singh & Singh, 2008). 
In this sense, in our study, two independent tests were carried out to 
affirm the antioxidant capacity of bee pollen and propolis extracts. For 
example, the DPPH assay is associated with the free radical scavenging 
activity promoted by the compounds present in the extracts, whereas the 
phosphomolybdate method (where Mo (VI) is reduced to Mo (V) in the 
presence of antioxidant compounds) is normally associated with total 
antioxidant capacity. 
Total antioxidant capacity (90.17 ± 7.38 mg AAE/g) go on hind with 
the data published by (Touzani et al., 2018), where seven Moroccan 
propolis samples collected from different areas in Morocco had total 
antioxidant activity ranging between 6.56 ± 0.82 and 90.87 ± 2.91 mg 
AAE/g. DPPH scavenging assay showed a powerful antiradical activity 
(IC50 = 0.17 ± 0.00 mg/mL), which is included in the range of Moroccan 
propolis, varied from 0.019 mg/mL to 1.190 mg/mL (Touzani et al., 
2018). Bee pollen is another bee product; it’s considered as a biological 
matrix very rich in natural antioxidants (Denisow & Denisow-Pietrzyk, 
2016). It was found that the total phenolic content in Polish bee pol-
len is 21.30 mg GAE/g (Rzepecka-Stojko, Stec, Kurzeja, Gawrońska, & 
Pawłowska-Góral, 2012), in Lithuanian bee pollen is 23.3 mg GAE/g 
(Čeksteryté et al., 2016). In the Egyptian bee pollen, the total phenolic 
contents were between 0.8 ± 0.07 and 2.3 ± 0.014 mg GAE/g (AbdEl-
salam, Foda, Abdel-Aziz, & Abd, 2018). The amount of total phenolic 
content in our bee pollen sample is (19.68 ± 0.12 mg GAE/g), which is 
higher than that signaled for Egyptian bee pollen and lower than that 
found in Polish and Lithuanian bee pollen. Flavonoids are considered as 
a powerful secondary metabolite, certainly, they are responsible for 
several biological properties. Bee pollen’s flavonoid content was previ-
ously evaluated by several studies. It was found in a range between 1.81 
± 0.040 and 4.44 ± 0.125 mg QE/g (Mayda, Özkök, Ecem Bayram, 
Gerçek, & Sorkun, 2020) in Turkish bee pollen and from 15.28 ± 0.04 to 
31.80 ± 0.13 mg QE/g in Malaysian bee pollen (Harif Fadzilah, Jaapar, 
Jajuli, & Wan Omar, 2017). Regarding free radical scavenging ability 
(DPPH), the concentration of bee pollen required to inhibit 50% of 
DPPH radical is 0.91 ± 0.02 mg/mL, which is lower than the published 
by (Mayda et al., 2020) for different bee pollen samples from Turkey, 
ranging between 1.29 ± 0.03 and 3.85 ± 0.03 mg/mL. 
The qualitative and quantitative phytochemical composition of bee 
products is strongly variable and depend on the ecosystems and harvest 
year (Bankova, 2009). In fact, the soil nature, weather conditions and 
Table 2 
Effect of interventions on body weight.  
Experimental groups Initial BW (g) % Change Final BW (g) % Change BW gain (g) % Change 
1 168.90 ± 4.22  – 212.56 ± 4.41b – 43.66 ± 0.19b – 
2 172.6 ± 5.11  2.19 200.4 ± 3.68b − 5.72 27.8 ± 0.12ab − 36.32 
3 175.37 ± 4.86  3.83 280.35 ± 6.81 a 31.89 104.98 ± 3.14ab 140.44 
4 168.45 ± 5.13  − 0.26 205.14 ± 5.37b − 3.49 36.69 ± 0.79ab − 15.27 
5 178.58 ± 4.46  5.69 263.74 ± 4.92ab 24.07 85.16 ± 2.28ab 95.05 
6 177.34 ± 3.28  4.99 298.78 ± 5.48a 40.56 128.44 ± 2.20a 194.18 
7 172.81 ± 3.10  − 2.55 248.62 ± 5.37ab − 16.78 71.81 ± 2.27ab − 44.58 
8 171.96 ± 3.11  − 3.03 292.76 ± 6.96a − 2.014 120.80 ± 3.85ab − 5.94 
9 174.75 ± 3.28  − 1.46 251.93 ± 5.23ab − 15.68 77.18 ± 2.8ab − 39.90 
10 170.73 ± 6.72  − 3.98 272.41 ± 6.58ab − 8.80 101.68 ± 3.38ab − 20.83 
11 172.37 ± 3.05  − 2.80 258.34 ± 5.19ab − 13.53 95.97 ± 2.14abcd − 25.28 
a: comparison between the group 1 and all groups, b: comparison between the group 6 and all groups, (the significance started at p < 0.05). 
Percentage changes (%) were calculated by comparing the diabetic control group with normal and the diabetic treated group with diabetic control. 
Table 3 
Effect of interventions on absolute and relative organs weights.  
Groups Kidney weight (g) Liver weight (g) Pancreas weight (g) kw/100gBw Lw/100 g Bw Pw/100 g Bw 
1 1.92 ± 0.07b 8.22 ± 0.39b 1.09 ± 0.05b 0.903 ± 0.015b 3.867 ± 0.088b 0.512 ± 0.011b 
2 1.84 ± 0.03b 7.41 ± 0.46ab 1.02 ± 0.03b 0.918 ± 0.008b 3.697 ± 0.125ab 0.508 ± 0.008b 
3 2.49 ± 0.09b 10.93 ± 0.81ab 1.47 ± 0.05b 0.888 ± 0.015b 3.898 ± 0.119ab 0.524 ± 0.008b 
4 1.84 ± 0.04b 7.79 ± 0.37b 1.00 ± 0.04b 0.896 ± 0.007b 3.797 ± 0.068b 0.487 ± 0.007b 
5 2.37 ± 0.07b 10.02 ± 0.56b 1.37 ± 0.02b 0.898 ± 0.010b 3.799 ± 0.080b 0.519 ± 0.002b 
6 2.12 ± 0.02a 7.76 ± 0.35a 1.19 ± 0.09a 0.709 ± 0.003a 2.597 ± 0.063a 0.398 ± 0.016a 
7 1.98 ± 0.09ab 8.20 ± 0.71ab 1.11 ± 0.04ab 0.796 ± 0.012ab 3.298 ± 0.102ab 0.446 ± 0.005ab 
8 2.49 ± 0.07ab 10.54 ± 0.58ab 1.47 ± 0.07b 0.849 ± 0.011ab 3.597 ± 0.094ab 0.501 ± 0.011b 
9 1.93 ± 0.05ab 8.31 ± 0.71ab 1.10 ± 0.03a 0.766 ± 0.009ab 3.298 ± 0.135ab 0.436 ± 0.005a 
10 2.31 ± 0.02ab 9.26 ± 0.58ab 1.33 ± 0.06b 0.847 ± 0.003ab 3.399 ± 0.088ab 0.488 ± 0.009b 
11 2.14 ± 0.09 ab 9.04 ± 0.49abcd 1.24 ± 0.07ab 0.828 ± 0.017ab 3.499 ± 0.094abcd 0.479 ± 0.013ab 
a: comparison between the group 1 and all groups, b: comparison between the group 6 and all groups, c: comparison between group 7 and group 11, d: comparison 
between group 8 and group 11 (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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the local plant source influence their composition and consequently 
gives its potential health benefits and a wide spectrum of biological 
activity including antidiabetic, antimicrobial, antitumor, anti- 
inflammatory, immunomodulatory and cardio protective activities 
(Pasupuleti, Sammugam, Ramesh, & Gan, 2017). 
4.2. Antidiabetic effect of bee pollen and propolis extracts 
Hyperglycemia is the main cause of diabetes complications, and it is 
one of the factors associated with morbidity and mortality (Vichaibun, 
Khananurak, & Sophonnithiprasert, 2019). Our results illustrate that 16 
weeks of treatment with D-glucose induced a significant increase in 
blood glucose, insulinemia and HOMA-IR index, which is in agreement 
with the finding of (El Midaoui, Haddad, & Couture, 2016). The mea-
surement of insulinemia is one of the most recommended parameters 
used for the diagnosis of T2D (Konate et al., 2014). Chronic hyper-
insulinemia induces a down regulation of insulin receptor phosphory-
lation and reversible reduction of receptor tyrosine kinase activity, 
leading to insulin resistance associated with type 2 diabetes mellitus 
(Catalano et al., 2014; Kanety, Moshe, Shafrir, Lunenfeld, & Karasik, 
1994). The present results showed that the co-administration of propolis 
or bee pollen extracts at two tested doses (100 and 200 mg/kg BW) are 
able to ameliorate the rise in blood glucose, HOMA-IR index and insu-
linemia. In the same sense, the combined treatment with propolis and 
pollen has remarkably reduced the level of all these parameters. Also, 
the diabetic animals expressed a very low value of HOMA-β and insulin 
sensitivity and a significant reduction in QUICKI (marker of insulin 
sensitivity) concurring with the findings of (Abdel Aziz et al., 2020). 
However, the co-administration of propolis, bee pollen or both showed a 
significant increase of these parameters, with the best data observed in 
the group which received the combined treatment (Group 11). This may 
be due to the reduction of pancreatic oxidative stress generated by 
chronic accumulation of blood glucose. Previous data revealed that 
phenolic compounds have a wide diversity of pharmacological activities 
and strong effects on numerous chronic diseases including diabetes 
(Chen, Gnanaraj, Arulselvan, El-Seedi, & Teng, 2019; Huang et al., 
2019). The outcome of (Ahmed, Hassan, Abdel-Twab, & Abdel Azeem, 
2017) showed that naringin has strong anti-hyperglycemic and anti- 
hyperlipidemic effects in nicotineamide/streptozotocine induced T2D 
in rats. Apigenin ameliorates glucose level, vascular dysfunction and 
regulates lipid metabolism as well as insulin resistance in T2D rats (Ren 
et al., 2016). In fact, naringin and apigenin were the most predominant 
phenolic compounds detected in our propolis and bee pollen samples, 
respectively. This supports the hypothesis of their contribution in the 
mechanism of the anti-hyperglycemic effect and management of insulin 
sensitivity. 
The report of (Chen et al., 2019) about phenolic acids and their 
mechanisms involved in the management of diabetes has shown that, 
ferrulic acid controls and reduces chronic blood sugar by stimulating 
insulin secretion and expression of GLUT4 and MAP kinase. Chlorogenic 
acid stimulates glucose transport by the translocation of GLUT4 and the 
activation of IRS-1 and PI3K signaling pathways. In addition, it inhibits 
hepatic Glc-6-Pasein db/db in mice homozygous for diabetes sponta-
neous mutation model. Ellagic acid is another phenolic acid that has 
strong antidiabetic effect, in fact it is able to inhibit IL-1 and TNF-α and 
hence, inhibits AP-1 and MAPK. Moreover, it also stimulates malon-
dialdehyde (MDA) level in the liver and kidney tissues in diabetic mice 
(Konate et al., 2014). Overall, the anti-hyperglycemic effect of propolis 
and bee pollen used in this study could be due to the interaction between 
these bioactive molecules through diverse signaling pathways (Fig. 6). 
4.3. Protective effect of bee pollen and propolis extracts on liver 
biochemical changes 
The liver plays a crucial role in glucose and lipid homeostasis, the 
plasma level of ALT, AST, LDH and ALP is an essential indicator 
reflecting the functional status of the liver. In this study, the diabetic 
group expressed a remarkable increase in serum levels of ALT, AST, ALP, 
and LDH (Fig. 5). These results were in agreement with those reported 
by (Oršolić, Sirovina, Končić, Lacković, & Gregorović, 2012). The high 
plasma level of ALT, AST, ALP, and LDH is an index of liver damage, 
indicating liver structural changes (Bakour et al., 2017), and hepatic cell 
necrosis, accompanied by the secretion of these enzymes into the 
bloodstream from the cytosol (Bakour et al., 2018). That could be 
attributed to the oxidative damage of ROS generated by diabetes 
(Kangralkar, Patil, & Bandivadekar, 2010). However, rats receiving 
propolis or bee pollen simultaneously with D-glucose expressed lower 
levels of ALT, AST, LDH and ALP. In the same context, the combined 
extracts co-treatment induced a remarkable recovery of these key en-
zymes of the liver function. Indeed, propolis and bee pollen prompted 
the protective effect and prevented the complications of diabetes 
(Fig. 6). The protective effect of propolis and bee pollen might be due to 
their richness on various phytochemical compounds (Table 1). Previous 
study reports that resveratrol has been revealed to exert hepato- 
protective action against oxidative stress-caused liver injury by acti-
vating Nrf2 signaling pathway and stimulating the production of 
Fig. 6. Schematic diagram showing a proposed mode of actions of bee pollen and propolis extracts in D-glucose induced type 2 diabetes, dyslipidemia and hepato- 
renal dysfunction. 
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glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), 
NADPH dehydrogenase quinine-1 (NQO1), heme oxygenase-1 (HO-1) 
and glutathione S-transferase (GST) (Jia et al., 2019). 
4.4. Protective effect of bee pollen and propolis extracts on kidney 
biochemical changes 
Our data indicate that free access to drinking water contained 10% of 
D-glucose for 16 weeks significantly increased the levels of creatinine, 
urea, and uric acid and decreased the total protein and albumin 
compared to non-diabetic control rats. These results are major sign of 
diabetic nephropathy, which is considered as one of the dangerous 
complications of diabetes (Al-Logmani & Zari, 2011). These results are 
consistent with previous studies by other authors (Al-Malki & El Rabey, 
2015; Balasubramanian, Gp, & Chatterjee, 2014). In diabetic groups the 
simultaneous administration of propolis or bee pollen extracts with daily 
ingestion of D-glucose showed a reduction in the levels of creatinine, 
urea, and uric acid, in contrast, a remarkable increase in albumin and 
total protein levels was shown. This change in plasma albumin levels 
induced by diabetes, may be attributed to inflammation or liver failure 
(Akirov, Masri-Iraqi, Atamna, & Shimon, 2017). This is in agreement 
with the results of (Oršolić et al., 2012), which shows that the co- 
treatment with propolis at a dose of 50 mg/kg BW significantly re-
duces plasma levels of urea, uric acid and creatinine. Quercetin pre-
sented in bee products has been proved to prevent renal injury through 
the modulation of Akt/mTOR pathway as a result of its antioxidant and 
anti-inflammatory action (Rusul F. Hasan, Altimimi, Alaridy, & Hadi, 
2020). The concurrent treatment with propolis and bee pollen (Group 
11) ameliorated these parameters and nearly restored them to their 
normal levels. This could be attributed to the synergistic effects between 
their bioactive molecules (Fig. 6). 
4.5. Protective effect of bee pollen and propolis extracts on dyslipidemia 
Type 1 diabetes (T1D) and T2D express two different forms of dys-
lipidemia. T1D most commonly associated with normal LDL-C and HDL- 
C levels and high value of TG. However, T2D is generally characterized 
by low levels of HDL-C and a normal level of LDL-C and a high level of 
TG (Molitch, 2006). The present study showed that diabetic animals 
have expressed a massive elevation in plasma TC, TG, LDL-C and VLDL 
accompanied by a significant decrease of serum HDL-C, index of dysli-
pidemia. Dyslipidemia contributes to the mechanism of oxidative stress 
in T2D (Aouacheri, Saka, Krim, Messaadia, & Maidi, 2015; Stahlman 
et al., 2013), leading to other chronic cardiovascular diseases (CVD) and 
atherosclerosis (Molitch, 2006). Atherosclerosis is usually associated 
with LDL oxidation (Matsuura, Hughes, & Khamashta, 2008). Previous 
studies have shown that propolis reduces lipid peroxidation in vitro and 
in vivo (Inokuchi et al., 2006; Matsuura et al., 2008). This could be the 
mechanism involved in the prevention of cardiovascular disease CVD. In 
this study, the treatment of diabetic rats with propolis has restored the 
normal values of lipid profile, this is in agreement with the findings of 
(Konate et al., 2014). Also the diabetic animal’s co-treated with bee 
pollen alone or in combination with propolis showed a significant 
decrease in TC, TG, LDL-C and VLDL, in parallel a significant increase in 
HDL-C. This confirms their preventive effect on diabetes induced dys-
lipidemia. Therefore, bee pollen and propolis, particularly their associ-
ation have the potential to prevent and reduce CVD. 
4.6. Protective effect of bee pollen and propolis extracts on body and 
organs weights changes 
Body weight gain is one of the most common symptoms of T2D, 
especially, when the glycemic status is uncontrolled. In the present 
study, the chronic administration of 10% D-glucose caused a significant 
increase in the final body weight and body weight gain in comparison 
with the normal group. This is in agreement with the results of (Ross 
et al., 2011), illustrating the association of T2D and obesity. Opposite 
toT1D, which is manifested by the body weight loss (Mohamed, Ahmed, 
Hozayen, & Ahmed, 2018). This may be explained by the anabolic effect 
of insulin and it ability to stimulate cell growth and promote storage of 
fatty acids in adipose and muscle tissue (Brown, Guess, Dornhorst, 
Taheri, & Frost, 2017). Hence, the co-administration of propolis at a 
high and a low dose and the co-administration of bee pollen at same 
doses have significantly reduced the body weight and the body weight 
gain compared to the diabetic group. The decrease of body weight 
following the co-treatment with propolis is more significant than bee 
pollen co-treatment. The body weight decrease of diabetic rats co- 
treated with propolis extracts is probably due to its repressive effect 
on PPARγ protein expression, which attenuated fat accumulation in 
adipocytes (Rayalam et al., 2007). In the same context, it was found that 
propolis administration inhibits cholesterol synthesis by decreasing he-
patic HMG-CoA reductase protein (Ichi et al., 2009). 
Also the Table 3 showed that the treatment with propolis or bee 
pollen does not affect the organs relative weight. The data illustrates 
that the treatment with D-glucose for 4 months caused a significant 
decrease of organs’ relative weight (liver, kidney and pancreas) in 
comparison with the control group, this goes in hand with the findings of 
(Bai, Zang, Ma, & Xu, 2016). However, the co-treatment with propolis 
alone, pollen alone or both had induced a marginal increase in kidney, 
liver and pancreas’s relative weight. This is consistent with results of 
(Mohamed et al., 2018). The liver weight loss may occur as a result of 
the breakdown of glycogen, lipids and proteins caused by lack of insulin 
in liver cells (Qaid & Abdelrahman, 2016). In general, the decrease of 
organs’ relative weights can be attributed to the destruction of its cells 
by the excess of free radicals generated through diabetes, which is 
illustrated by the biochemical parameters. 
5. Conclusion 
Overall, the results of this study showed for the first time that co- 
administration of propolis and bee pollen extracts, especially their 
combination, are able to attenuate the T2D caused by a high-glucose 
intake. The role of these natural ingredients involves prevention of hy-
perglycemia, insulinemia, HOMA-IR index, HOMA-β, Insulin sensitivity, 
pancreatic β-cell function and lipid prolife. Furthermore, these natural 
products ameliorate hepatotoxicity and nephrotoxicity as diabetic 
complications. 
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